2 enrolling by invitation, 1 completed, 1 terminated. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 2 |
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Terminated 1 |
Follow treated group: new trials by email Literature Review of treated group trials Research Report on treated group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents treated group - Histiocytosis,Langerhans-Cell | Phase 1 / Phase 2 | Enrolling by invitation | Second Affiliated Hospital of Wenzhou Medical University | 2 | 2026-10-20 | 2026-10-22 |
| Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents treated group - Histiocytosis, Langerhans-Cell | Phase 1 | Enrolling by invitation | Second Affiliated Hospital of Wenzhou Medical University | 6 | 2025-02-06 | 2025-03-30 |
| MyDiabby Healthcare Vs Diary in Gestational Diabetes Mellitus. Control group, Treated group - Gestational Diabetes | Completed | Hôpital NOVO | 668 | 2022-08-02 | 2024-09-19 | |
| Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa Denosumab subcutaneous injections, Placebo subcutaneous injections - Anorexia Nervosa | Phase 3 | Terminated | University Hospital, Montpellier | 2 | 2016-06-01 | 2019-01-07 |
Histiocytosis, Langerhans-Cell (2) · Anorexia Nervosa (1) · Diabetes Mellitus (1) · Diabetes, Gestational (1)
Second Affiliated Hospital of Wenzhou Medical University (2) · Hôpital NOVO (1) · University Hospital, Montpellier (1)
China (2) · France (2)
Dr Catherine Campinos (1) · Pr Christophe Poncelet (1)